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PPrognostic Markers in CAD
oronary Calcium Independently
redicts Incident Premature Coronary Heart
isease Over Measured Cardiovascular Risk Factors
ean Three-Year Outcomes in the
rospective Army Coronary Calcium (PACC) Project
llen J. Taylor, MD, Jody Bindeman, BSN, Irwin Feuerstein, MD, Felix Cao, MS, Michael Brazaitis, MD,
atrick G. O’Malley, MD, MPH
ashington, DC
OBJECTIVES We sought to examine the independent predictive value of coronary artery calcium detection
for coronary outcomes in a non-referred cohort of healthy men and women ages 40 to 50
years.
BACKGROUND Existing studies have suggested that coronary calcium might have incremental predictive
value for coronary outcomes above standard coronary risk factors. However, additional data
from non-referred and younger populations are needed.
METHODS Participants (n  2,000; mean age 43 years) were evaluated with measured coronary risk
variables and coronary calcium detected with electron beam tomography. Incident acute
coronary syndromes and sudden cardiac death were ascertained via annual telephonic
contacts, with follow-up (mean, 3.0  1.4 years; range, 1 to 6 years) in 99.2% of the cohort.
RESULTS Coronary calcium was found in 22.4% of men and 7.9% of women. A total of 9 acute events
occurred in men at a mean age of 46 years, including 7 of 364 men with coronary calcium
(1.95%) and 2 of 1,263 men without coronary calcium (0.16%; p  0.0001 by log-rank). No
events occurred in women. In these men, coronary calcium was associated with an 11.8-fold
increased risk for incident coronary heart disease (CHD) (p  0.002) in a Cox model
controlling for the Framingham risk score. Among those with coronary artery calcification,
the risk of coronary events increased incrementally across tertiles of coronary calcium severity
(hazard ratio 4.3 per tertile). A family history of premature CHD was also predictive of
incident events. The marginal cost effectiveness, assuming a 30% improvement in survival
associated with primary prevention among at-risk men, was modeled to be $37,633 per
quality-adjusted life year saved.
CONCLUSIONS In young, asymptomatic men, the presence of coronary artery calcification provides substan-
tial, cost-effective, independent prognostic value in predicting incident CHD that is
incremental to measured coronary risk factors. (J Am Coll Cardiol 2005;46:807–14)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.049© 2005 by the American College of Cardiology Foundation
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Tecent guidelines have highlighted the potential use of
natomically based coronary heart disease (CHD) risk
ssessments to refine the risk prediction provided through
lobal risk assessment tools such as the Framingham risk
core (FRS) (1–4). One such approach uses computed
omography (CT) to detect coronary artery calcium (CAC),
finding that is clearly related to an increased risk of
ncident CHD (5,6). However, controversy remains regard-
ng whether, and to what extent, detection of CAC provides
ncremental risk prediction beyond conventional coronary
isk factors. With the exception of the South Bay Heart
atch (7), studies examining the relationship between
From the Departments of Medicine and Radiology, Walter Reed Army Medical
enter, Washington, DC. Supported by the Congressionally directed, Peer Reviewed
edical Research Program, grant number ERMS 00239017-00216. The opinions or
ssertions herein are the private views of the authors and are not to be construed as
eflecting the views of the Department of the Army or the Department of Defense.I
Manuscript received February 25, 2005; revised manuscript received April 29,
005, accepted May 17, 2005.oronary risk factors, coronary calcium, and outcomes have
sed self-reported risk factor data (8–11), introducing a
otential source of error and bias in the analyses (10,12).
The Prospective Army Coronary Calcium (PACC)
roject is a prospective cohort study of U.S. Army personnel
xamining the incremental prognostic value of CAC beyond
he FRS for the determination of CHD prognosis. Initiated
n 1998, we enrolled healthy asymptomatic men and women
etween the ages of 40 and 50 years who were presenting for
periodic physical examination. Herein, we report the
elationship between CAC and CHD outcomes of myocar-
ial infarction, hospitalized unstable angina, and sudden
ardiac death based on mean three-year follow-up of the
ACC project cohort.
ETHODS
his protocol was approved by the Department of Clinical
nvestigation of Walter Reed Army Medical Center and
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Coronary Calcium, Risk Factors, and Outcomes September 6, 2005:807–14unded under the Congressionally directed, peer-reviewed
edical research program of the Department of Defense.
he methods of the PACC project have been previously
ublished (13). Briefly, all active-duty Army personnel, ages
0 to 50 years old and stationed within the National Capital
rea of the Walter Reed Health Care System, were re-
ruited at the time of a periodic, Army-mandated physical
xamination. Individuals with a history of CHD or who
ndicated a history of angina pectoris by the Rose question-
aire (14) were ineligible. Between October 26, 1998, and
ebruary 19, 2003, 2,259 eligible individuals were screened
nd 2,000 men and women provided written informed
onsent to undergo electron beam computed tomography
EBCT) and the cardiovascular risk-screening program.
ne male participant failed to complete the coronary CT
can, leaving 1,999 participants for analysis.
ACC Project procedures. Participants provided details
f their medical history, lifestyle behaviors, and psychosocial
istory. Ethnicity was self-reported. Medical history in-
luded a history of hypertension, diabetes mellitus, hyper-
holesterolemia, and current medications. Smoking was
elf-reported as current, recent (within six months) or
emote (more than six months ago) use of any inhaled
obacco products, except for intermittent cigar consump-
ion. A family history of CHD included a history of sudden
eath, myocardial infarction, or coronary revascularization
n a relative before the age of 55 (males) or 65 (females)
ears (15). Family history data were collected separately for
rst- (parents, siblings) or second-degree (grandparents,
unts, uncles, cousins) relatives.
Resting blood pressure was measured using an automated
phygmomanometer, and was recorded as the average of
hree seated measurements taken 5 min apart. Hypertension
as defined as either a systolic blood pressure of 135 mm
g, a diastolic blood pressure of 85 mm Hg (16), or a
istory of hypertension (treated or untreated). Height and
eight were measured, and body mass index (BMI) was
alculated as weight/height2 (kg/m2). Waist girth was mea-
ured as the maximum abdominal circumference between
he iliac crest and umbilicus. The metabolic syndrome was
lassified according to the recommendations of the National
holesterol Education Program (15). Fasting blood was
Abbreviations and Acronyms
BMI  body mass index
CAC  coronary artery calcium
CHD  coronary heart disease
CT  computed tomography
EBCT  electron beam computed tomography
FRS  Framingham risk score
HDL  high-density lipoprotein
LDL  low-density lipoprotein
PACC  Prospective Army Coronary Calcium
QALY  quality-adjusted life yearsollected for the measurement of total cholesterol, low- uensity lipoprotein (LDL) cholesterol, high-density li-
oprotein (HDL) cholesterol, triglycerides, serum glucose,
emoglobin A1C, lipoprotein(a), homocysteine, fibrinogen,
nd insulin. Measurement of serum C-reactive protein was
dded during the course of the study. The predicted 10-year
RS for incident CHD was calculated using measured risk
actor variables as specified within regression equations from
he Framingham Heart Study (17).
The baseline coronary risk factors and their relationships
o CAC in the PACC project have been previously reported
10,18,19). Variables having significant univariate relation-
hips with CAC included gender, Caucasian race, hyper-
ension, a family history of CHD, and metabolic syndrome.
articipants with CAC also had significantly higher 10-year
RS for CHD, BMI, waist girth, blood pressure (both
ystolic and diastolic), total cholesterol, LDL cholesterol,
riglycerides, and fasting glucose, and lower HDL choles-
erol. All measured emerging cardiovascular risk factors
e.g., lipoprotein(a), homocysteine, fibrinogen, serum insu-
in, and C-reactive protein) were unrelated to CAC.
BCT scanning and analysis. For the measurement of
AC, EBCT was performed using an Imatron C-150 LXP
canner (Imatron Corp., South San Francisco, California)
alibrated daily with air and water phantoms and twice-
onthly with contrast and resolution phantoms. Images
ere obtained using a 40- to 50-slice (3 mm thickness)
rotocol with image acquisition triggered to 60% to 80% of
he electrocardiographic RR interval while respirations were
eld. Scans were interpreted in a blinded manner by an
xperienced radiologist (I. M. F.) using the Agatston
coring method (20). A focus of coronary calcium was
efined as the presence of four or more contiguous pixels
ith 130 Hounsfield units. A total CAC score was
etermined from the sum of individual scores of the four
ajor epicardial coronary arteries. A scan was considered
ositive for CAC when the total CAC score was 0
18,21).
HD outcomes. The published analysis plan of the
ACC project pre-specified an actuarial five-year analysis of
he relationship between CAC and CHD events (13). To
chieve this, the vital status of the cohort was tracked
hrough annual telephonic contacts during which a struc-
ured interview was conducted. Detailed interviews on a
eported possible CHD event were conducted by experi-
nced nurse coordinators who obtained details and re-
uested source documents (hospital records) for review.
ecords of the CHD event were independently reviewed by
wo researchers and a third independent cardiologist to
onfirm the nature of the CHD event. These reviews were
onducted blinded to all cardiovascular risk factor and CAC
ata. This analysis reports adjudicated acute CHD events
efined as sudden cardiac death (sudden, unexpected death
ithin one hour of the onset of symptoms), myocardial
nfarction (documented by elevated cardiac biomarkers and
clinical course of care consistent with this diagnosis), and
nstable angina pectoris (acute-care hospitalization for new-
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September 6, 2005:807–14 Coronary Calcium, Risk Factors, and Outcomesnset or rapidly progressive chest pain or another ischemic
quivalent symptom with demonstrated inducible ischemia
r obstructive coronary artery disease and a course of care
onsistent with this diagnosis). Stable chest pain syndromes
nd asymptomatic revascularization procedures (one asymp-
omatic patient underwent percutaneous coronary revascu-
arization after a strongly positive screening stress test) were
ot included.
As of October 26, 2004, 1,983 of the 1,999 participants
ith coronary CT scans remained in the study, and their
ital status was determined using direct telephonic contact
99.2% follow-up). The mean follow-up duration was 3.0
.4 years. Among the 16 participants not included in this
nalysis, 5 were known to be alive and well, but withdrew
onsent for continued participation before their first sched-
led follow-up. One died in the Pentagon terrorist attack of
eptember 11, 2001. Ten participants were lost to follow-
p, although none were identified in a search of the social
ecurity death index or were known to have accessed the
ilitary or civilian health care network (ascertained through
ilitary administrative health care databases) under a car-
iovascular diagnosis or procedure code. These patients
ere not included in the present analysis.
tatistical analysis. The primary analysis was on the rela-
ionship between CHD events and CAC. For univariate
nalyses, continuous variables were compared using a t test
or independent groups and categorical variables were com-
ared using the chi-square test. Multivariate analysis was
erformed using Cox proportional hazards modeling and
tepwise methods to examine the independent predictive
alue of CAC for CHD events. This analysis was conducted
or men only because no women experienced a CHD event
uring follow-up. Two models were established: model I
xamined how the presence of CAC predicted CHD, and
odel II further investigated how the incremental severity
f CAC predicted CHD. Model II was limited to those
articipants with any detectable CAC, with CAC coded in
ertiles by CAC score. Both forward and backward stepwise
ethods were used to examine the unique predictive value
f CAC. In forward stepwise models, only variables that
ignificantly predicted CHD events (p  0.05) were se-
ected and entered into the equation. In backward stepwise
ethods, all variables were selected and entered into the
quation first, and then removed in each step beginning
ith the smallest chi-square value until the remaining
ariables significantly predicted the CHD event. Partici-
ants were censored from models after the last follow-up
ontact. Because of the small number of CHD outcomes,
he FRS was the only covariate in a parsimonious model. An
xploratory analysis evaluating both the FRS and a family
istory of premature CHD was also conducted. Family
istory was categorized as absent (no family history; 68%),
nd either a first- or second-degree or both first- and
econd-degree family history (32%), because both have been
eported to have predictive value in younger patient popu-
ations (22). Models incorporating a more traditional defi- Cition (15) of premature family history restricted to first-
egree relatives of those with CHD were also evaluated and
howed similar but non-significant trends (data not shown).
wenty participants (none with a CHD outcome) with
issing data for family history were excluded from the
odels in which either first- or second-degree or both
egrees of family history was used as a predictor. Cox
egression results were expressed as hazard ratios and
eported with 95% confidence intervals. Hazard ratios for
he FRS are presented per 1% increase in 10-year risk. All
nalyses were performed by an expert statistician (F.C.)
sing SPSS for Windows (version 12.0, SPSS Inc., Chi-
ago, Illinois). To extend the pre-study sample size calcu-
ations as previously published (13), a post-hoc sample size
nalysis was performed using Sample Power (version 2.0,
PSS Inc.). Data are presented as mean  standard devia-
ion. A two-tailed p value of p  0.05 was considered
ignificant.
ost effectiveness analysis. We previously published a
ecision analysis assessing the theoretical cost effectiveness
f atherosclerosis imaging in a low-risk population (23).
sing the current CHD outcomes analysis, we updated the
ost effectiveness analysis using the same decision tree and
ncorporated the actual relative risk estimates observed,
sing the 95% confidence limits in the sensitivity analysis.
n the model we used Bayesian logic to incorporate EBCT
nto risk prediction, multiplying the adjusted predicted risk
etermined by the FRS by the adjusted relative risk increase
onferred by the CAC score. In other words, the presence of
AC multiplied the absolute risk by the adjusted relative
isk associated with CAC from this analysis. A CAC score
f zero was the referent value. We defined “at risk” as having
calculated CHD risk using the FRS of1% per year. This
utoff was chosen because primary prevention has been
roven to be cost effective principally when risk exceeds this
hreshold. The base case assumptions and their derivation
ources are included in detail in the prior publication
23). In brief, the annual costs for medications if “at risk”
as $400; the utility of being “at risk” was 0.98; the
fficacy of primary prevention therapy for “at-risk” indi-
iduals was to extend life expectancy by 1.5 years among
at-risk” patients who would live an average of 5 years less
han a cohort not “at risk”—in other words, primary
revention would be associated with a 30% relative risk
eduction in overall mortality among an at-risk 40-year-
ld screening population.
ESULTS
he demographic and descriptive characteristics of the
,983 participants are shown in Table 1, grouped separately
y gender. Caucasians were the majority of the cohort. The
roup was predominately well-educated. For men, the most
revalent cardiac risk factors were hypertension (30.8%) and
ither a first- or second-degree (31.7%) family history of
HD. The metabolic syndrome was present in 6.6%, and
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Coronary Calcium, Risk Factors, and Outcomes September 6, 2005:807–14.9% of participants were active tobacco users. The mean
0-year FRS for CHD was 4.6  2.7%. Coronary artery
alcification was detected in 22.4% of male participants,
ith a mean CAC score of 20  111. Coronary artery
alcification was detected in 7.9% of female participants,
ith a mean CAC score of 3  20. Among the 4.4% (72 of
,627) of the male study cohort with a 10-year FRS 10%,
4 had CAC. Thus, a total of 412 patients had either
levated FRS (10%) or CAC present.
During the follow-up period (mean, 3.0  1.4 years;
ange, 1 to 6 years), there were nine acute CHD events
definite myocardial infarction, unstable angina, or CHD
eath). All of these events occurred in men, with a mean age
f 43 years. Among these men, the mean age at the time of
he event (46  2 years [at time of event] vs. 46  3 years
able 1. Characteristics of the Study Participants Included in
his Report*
Variable
Men
(n  1,627)
Women
(n  356)
ge (yrs, mean  SD) 42.9  2.8 42.8  2.7
aucasian race 71.8% 56.2%
frican American race 17.8% 30.6%
ollege-educated 82.6% 75%
ardiac risk factors
Hypertension 30.8% 19.1%
1st-degree family history of CHD 18.5% 20.4%
Either 1st- or 2nd-degree or both
degrees of family history for CHD
31.7% 31.5%
Metabolic syndrome 6.6% 3.7%
Current tobacco use 6.9% 11.2%
Diabetes mellitus 0.8% 0%
0-yr Framingham risk index, CHD 4.6  2.6 1.4  1.2
0-yr Framingham risk index, CVD 7.3  3.9 3.2  2.5
oronary artery calcification score
Mean 19.5  110.7 3.3  20.0
Median 0 0
CAC score  0 1,263 (77.6%) 328 (92.1%)
CAC score  1–9 120 (7.4%) 11 (3.1%)
CAC score  10–44 120 (7.4%) 8 (2.2%)
CAC score 45 124 (7.6%) 9 (2.5%)
aecke Sports index† 3.0  1.0 2.6  1.2
ody mass index (kg/m2) 27.8  3.5 25.9  3.7
aist girth (cm) 95.8  24.9 82.3  10.1
ystolic blood pressure (mm Hg) 124.3  12.0 115.5  13.4
iastolic blood pressure (mm Hg) 77.6  8.8 72.3  9.1
otal cholesterol (mg/dl) 204.2  36.1 195.8  34.9
DL cholesterol (mg/dl) 128.5  31.4 112.1  30.0
DL cholesterol (mg/dl) 50.4  12.62 65.03  16.10
riglycerides (mg/dl) 129.8  86.5 88.6  51.2
asting glucose (mg/dl) 92.7  11.1 87.4  8.9
emoglobin A1C (%) (n  1,581) 5.4  0.6 5.3  0.4
ipoprotein(a) (mg/dl) 30.1  33.5 38.1  41.3
omocysteine (mol/l) 9.6  2.5 8.0  3.6
ibrinogen (mg/dl) 315.2  58.9 337.8  65.5
nsulin (U/ml) 8.0  6.0 8.2  4.9
-reactive protein (mg/l)‡ 1.9  2.2 2.4  2.5
Mean  standard deviation; †Baecke Sports index score ranges from 1 to 5, 5 being
ost active; ‡C-reactive protein, n  832 (men) and 184 (women).
CAC  coronary artery calcium; CHD  coronary heart disease; CVD 
erebrovascular disease; HDL  high-density lipoprotein; LDL  low-density
ipoprotein.at last follow-up]) and FRS (5.7  2.6% vs. 4.6  1.9%; A 0.19) was similar in those with and without CHD
vents. Four events occurred in men with a 10-year FRS
6%, and five occurred in men with a FRS between 6% and
0%. No events occurred in the 72 men with an FRS above
0%. Five of the nine events occurred in men with either a
rst- or second-degree family history of premature CHD (n
505).
The CHD events occurred in 7 of 364 men with CAC
1.95%) and 2 of 1,263 without CAC (0.16%; p  0.0001
y log-rank) (Table 2, Fig. 1). Cox regression showed that
he presence of any CAC was associated with an 11.8-fold
ncreased risk for acute CHD (p  0.002) after controlling
or the FRS (Table 3). Among those men with CAC
resent, the risk of CHD related to increasing severity of
AC was found to be incremental across CAC tertiles
hazard ratio, 4.3 per quartile; p  0.036) after controlling
or the FRS (Table 4, Fig. 2). These significant relation-
hips between CAC and CHD outcomes were marginally
eaker in exploratory models controlling for both the FRS
nd a family history of premature CHD (Tables 3 and 4 for
odel II). A post-hoc sample size analysis indicated that,
sing the observed prevalence of CAC, hazard rates for
HD outcomes, and time frame of this study, a total sample
f 1,200 patients had an 80% power to find a statistically
ignificant result. The actual power of this study was 91%.
ost effectiveness analysis. Using the adjusted relative risk
ssociated with having CAC in this cohort with its associated
5% confidence interval, the marginal cost effectiveness of
ncorporating EBCT into a conventional risk prediction as-
essment was projected to be $37,633/quality-adjusted life year
QALY), ranging from $31,500/QALY using the upper ad-
usted relative risk limit estimate of 60, to $500,000/QALY
sing the lower adjusted relative risk limit estimate of 2 (Fig.
). This was sensitive to the efficacy of primary prevention at
able 2. The Distribution of CHD Events by Coronary
alcium, Framingham Risk Score Categories, and Family
istory of CHD
Variable
CHD Events
nYes No
oronary calcium
Present 7 357 364
Absent 2 1,261 1,263
oronary calcium score tertiles
CAC score  1–9 0 120 120
CAC score  10–44 2 118 120
CAC score 45 5 119 124
ramingham risk score
6% 4 1,233 1,237
6%–10% 5 311 316
10% 0 72 72
amily history of CHD
No family history 4 1,093 1,097
With either 1st- or 2nd-degree
family history
2 411 413
With both 1st- and 2nd-degree
family history
3 94 97bbreviations as in Table 1.
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September 6, 2005:807–14 Coronary Calcium, Risk Factors, and Outcomesmproving overall survival. When the relative improvement
n overall survival associated with primary preventive mea-
ures (measures unique to at-risk populations: aspirin,
tatins, lower goals for blood pressure and cholesterol) was
ssumed to be 25% (Fig. 3), the marginal cost effectiveness
as $100,000/QALY (ranging from $1,000,000.00/
ALY to $79,000.00/QALY using the lower to upper
onfidence interval on the RR estimates); when the efficacy
f primary prevention was assumed to be a 45% relative
mprovement in survival, the marginal cost effectiveness was
$13,000.00/QALY (ranging from $22,000/QALY to
11,500/QALY).
ISCUSSION
he results of this pre-specified, mid-term analysis of the
ACC project support the presence of a strong, indepen-
ent relationship between CAC and premature, incident
HD in men. This finding, from a cohort of non-referred
tudy participants with measured cardiovascular risk vari-
igure 1. Hazard ratio plot for coronary heart disease (CHD) events
ncluding death, unstable angina, and myocardial infarction for male
rospective Army Coronary Calcium project participants with () (n 
64) and without () (n  1,263) coronary artery calcium (CAC).
Table 3. Cox Models Evaluating the Incremen
Presence on the Risk of CHD Events in Men
Variable
Hazard
Ratio
Model I: controlling for Framingham risk score only
Framingham risk score 1.10
Any CAC 11.82
Model II: controlling for Framingham risk score and
Framingham risk score 1.10
Family history of CHD 2.53
Any CAC 10.75Framingham risk score per 1% absolute risk change.
Abbreviations as in Table 1.bles and complete follow-up, persisted after controlling for
he FRS, thereby supporting the concept that CAC screen-
ng is an incremental tool in the identification of individuals
t increased risk for CHD.
Many studies have examined the relationship between
AC, coronary risk factors, and CHD events (7–11,24,25).
lthough each of these studies has reported an independent
elationship between CAC and either mortality or CHD
vents, there is a substantial degree of variability in the
eported strength of this relationship. A recent meta-
nalysis (6) concluded that three factors, including the
anner of risk factor assessment, the adjudication of out-
omes, and the inclusion of women in the cohort, accounted
or most of these differences. The lowest estimate of the
ncremental value of coronary CT comes from the only
tudy (an analysis limited to non-diabetic participants of the
outh Bay Heart Watch [7]) that used measured rather than
istorical risk factor data. Inaccuracy in the reporting of
istorical risk factors potentially induces bias in favor of the
ore accurately measured variable, CAC (8–11,24,25).
hus, use of measured risk factors, as in the PACC project,
s the only fully acceptable means of ascertaining the true
ncremental value of CAC scanning. Outcome assessments
linded to clinical risk factor and CAC scores are crucial to
bjectively categorize the observed events. Lastly, for a given
ge, women have lower FRS, lower CAC scores, and a
ower event rate (26). Thus, combining genders in any
nalysis of CAC and outcomes consequently increases the
eported relative risk of higher CAC scores (observed more
ommonly in men), an effect that is magnified in the
ixed-gender cohorts that are primarily male. The current
nalysis of the PACC project adheres to each of these
ssential study and analysis components.
Direct measurement of coronary risk factors incorporated
nto a global risk scoring algorithm, such as the FRS, is a
ecessary starting point in the evaluation of CHD risk.
owever, the FRS incompletely identifies CHD risk (27)
nd may lead to systematic overestimation of risk in lower-
isk populations. Coupled with an increasing recognition of
he low specificity (28) of defined “risk factors” as a direct
onsequence of lowered thresholds in risk factors (for
xample, for blood pressure and cholesterol [15]), plaque
urden assessments offer a quantitative, anatomic, disease-
redictive Value of Coronary Calcium
p
Value
95% Confidence
Interval
1,627)
0.37 0.90–1.35
0.002 2.45–56.93
ly history of CHD (n  1,607)
0.40 0.89–1.35
0.043 1.03–6.20
0.003 2.23–51.84tal P
(n 
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Coronary Calcium, Risk Factors, and Outcomes September 6, 2005:807–14ased method of refining the clinical assessment of CHD
isk. Consistent with this, the assessment of CAC in
rimarily intermediate-risk individuals has been advocated
n several recent guidelines and position statements (1–3).
he PACC project data support this general concept and
hallenge the notion that plaque burden assessments should
ot be applied to younger populations at lower absolute
HD risk. Potential advantages of screening individuals 40
o 50 years of age include the generally lower prevalence of
AC limiting the potential for overidentification of indi-
iduals identified as at risk because of the dominant rela-
ionship between age and CAC. Furthermore, effective
herapies arising out of such a screening approach can
nclude lifestyle modifications through a case management
pproach (29) and low-cost effective pharmacotherapies
uch as aspirin and generic statins.
Concerns about cost effectiveness are critically important.
s our revised cost effectiveness analysis suggests, a screen-
igure 2. Hazard ratio plot for coronary heart disease (CHD) events
ncluding death, unstable angina, and myocardial infarction for male
rospective Army Coronary Calcium project participants with coronary
Table 4. Cox Models Evaluating the Incremen
Risk of CHD Events in Men With Coronary
Variable
Hazard
Ratio
Model I: controlling for Framingham risk score only
Framingham risk score 1.06
Tertile CAC 4.32
Model II: controlling for Framingham risk score and
Framingham risk score 1.09
Family history of CHD 4.23
Tertile CAC 4.80
Framingham risk score per 1% absolute risk change. Tertile
Abbreviations as in Table 1.alcium (n  364) categorized into calcium score tertiles. CCS  coronary
alcium score.
y
Cng approach including a global risk assessment tool and
oronary calcium imaging for CHD risk detection is rela-
ively cost effective even when considered across long time
orizons of modestly effective preventive therapies. Impor-
antly, cost effectiveness is highly dependent on the efficacy
f primary CHD prevention. This implies that, after the
dentification of increased CHD risk, full application of,
nd adherence to, preventative measures becomes critical.
owever, because of the low event rate in the overall
opulation, even among those with CAC, unnecessary
esting should be avoided. Thus, criteria should be sought
or the optimal selection of low-risk individuals with the
reatest likelihood of benefit from CAC screening.
tudy limitations. The data within this study are general-
zable to healthy, physically active individuals from whom
he U. S. Army recruits volunteers. Prior studies in this
opulation have confirmed the generalizability of data from
.S. Army cohorts. As expected, based on the younger age
f the study population, the CHD event rate was low.
otable, however, is that these individuals all suffered
remature CHD events at a mean age of 46 years. Further-
ore, it is notable that the actuarial event risk in those men
ith CAC in this pre-specified analysis was approximately
% per year overall, with a demonstrable gradient of risk
bserved across higher CAC scores. Low event rates do
igure 3. Three-dimensional bar graph showing the interaction of the
elative risk reduction (RRR) of coronary interventions and the total
roportion of the screened population to be considered as at risk (using
oth the Framingham risk score [FRS] and coronary calcium testing
ogether) on cost effectiveness (quality-adjusted life years [QALY]). The
alue of Coronary Calcium Severity on the
um Present
p
Value
95% Confidence
Interval
364)
0.67 0.81–1.38
0.036 1.10–16.97
ly history of CHD (n  357)
0.51 0.84–1.42
0.013 1.36–13.13
0.034 1.13–20.44
is is referent to tertile 1—CAC score 1–9.tal V
Calci
(n 
famiellow bar indicates the base case for the Prospective Army Coronary
alcium project. CAC  coronary artery calcium.
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eyond the FRS, and also diminish the precision of our risk
stimates.
The present analysis is underpowered to exclude a rela-
ionship between CAC and CHD events in women. Data
rom Raggi et al. (26) indicate that such a relationship does
xist with respect to total mortality, but further study in
arge female cohorts is needed, specifically with respect to
ardiovascular-specific outcomes.
Sensitivity analysis on the effect of the estimated relative
isk on cost effectiveness of screening suggests that a strategy
f adding CAC to global coronary risk assessments would
e cost effective across a broad range of relative risk
ssociated with CAC. The cost effectiveness of screening for
AC is sensitive to the efficacy of primary prevention
nterventions (e.g., lifestyle and medications) in prolonging
uality-adjusted survival. The Multiple Risk Factor Inter-
ention Trial did show an 8% relative risk reduction at 10.5
ears in overall mortality during an era of less effective risk
actor interventions (30). Thus we feel that it is reasonable
o assume that there may be at least a 30% relative risk
eduction for primary prevention strategies among higher-
isk individuals over a 30- to 40-year lifetime horizon.
owever, this is unproven.
ONCLUSIONS
lthough further studies including women and ethnic
inorities are needed to extend these data, the PACC
roject, including the use of measured coronary risk factors
nd complete follow-up data, has shown the incremental
redictive value of CAC over conventional risk factors for
remature CHD outcomes. Beyond this demonstration of
ncremental prognostic value, important questions such as
hose of effectiveness and cost effectiveness remain. Al-
hough these questions are best answered through dedicated
rospective clinical trials, the costs, ethics, and feasibility of
uch trials are formidable obstacles to their completion.
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